Educational article

AWaRe: Access, Watch, Reserve

WHO AWaRe distinguishes Access, Watch and Reserve groups for antibiotic-use policy. Access includes important agents for common infections, Watch needs particular monitoring because of resistance concerns, and Reserve…

Overview

WHO AWaRe distinguishes Access, Watch and Reserve groups for antibiotic-use policy. Access includes important agents for common infections, Watch needs particular monitoring because of resistance concerns, and Reserve is retained for selected situations. The 2025 classification was checked as a current reference.

Biology and practical meaning

AWaRe does not measure an isolate’s susceptibility or rank drug strength. Reserve does not mean activity against every pathogen. The 2022 AWaRe book provides clinical educational guidance with subsequent updates; the 2025 classification supports use monitoring. Reports retain the classification year.

AWaRe groups
ConceptMeaning
AccessImportant options for many common infections.
WatchParticular attention to use and resistance risk.
ReserveRetained for selected difficult situations; not universal coverage.

Spectrum, exposure and AST

Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.

Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.

S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.

Current source edition

The 2025 AWaRe classification was checked for antibiotic-use evaluation and monitoring. The 2022 WHO AWaRe antibiotic book is a separate guide with subsequent updates; classification and clinical-source years must not be substituted for each other.

Sources

Read next

Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.

Open interactive reader